Little Falls-based Cantel Medical Corp. announced Tuesday it has appointed George L. Fotiades its new CEO and president, effective immediately.
Fotiades, who has succeeded Jorgen B. Hansen, will also serve on the company’s board of directors.
“It has been a privilege to lead the team at Cantel. During my tenure, we executed on our ambitious strategy, strengthening Cantel’s business and global reach. By doing so, we have taken the Company’s mission of saving lives through infection prevention to the next level. I am proud of what we have accomplished together,” Hansen said.
Fotiades has more than 35 years of experience in the health care and consumer products industries, both as an operator and investor. He’s been a member of Cantel’s board since 2008 and most recently served as operating partner at Five Arrows Capital Partners.
“Cantel has an excellent market position and many opportunities ahead for both organic growth and continued acquisition activity,” Fotiades said. “I look forward to working with the Board and the Executive Leadership Team in my new role to improve our operating model and performance, drive organic growth, attract and cultivate top leadership talent, and identify attractive acquisition candidates and expansion opportunities.”
He previously served as president and chief operating officer of Cardinal Health, where he helped create Cardinal’s Pharmaceutical Technologies & Service segment. After the segment’s sale to The Blackstone Group in 2007, Fotiades became chairman of the new company, which became Catalent Inc.
“On behalf of the board, I am very pleased to appoint George as Cantel’s new president and CEO. His experience leading companies through significant growth, creating organizational capabilities on a global scale, and integrating acquired businesses make him the ideal candidate to lead Cantel at this juncture. George has been a key contributor to the Board for over a decade and will make a seamless transition to this role. The board and I look forward to working with George in his new capacity to support the next phase of Cantel’s development,” Charles M. Diker, chairman of the board, said.